Bioceltix is ​​initiating the registration process for a drug for equine arthritis. The company has submitted an application to the European Medicines Agency.

Another important milestone in the history of Bioceltix. The publicly traded veterinary company has submitted an application to the European Medicines Agency (EMA) for a positive recommendation for the stem cell-based drug BCX-EM for equine arthritis. The excellent results from the product’s clinical trial confirmed its efficacy and safety. The drug’s therapeutic effect persists even […]

Puls Biznesu: Dog medicines are heating up Bioceltix

Dog medications are heating up Bioceltix, we read in Puls Biznesu. The same goes for the results of this year’s “Listed Company of the Year,” as we mark the 26-year history of the ranking as: Leader in the Success category in 2024, Leader in the Development Prospects category, and 3rd place overall (tied with Vercom […]